Showing results 3 to 7 of 7
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology | 2006 | 218 | ||
2013 | 133 | |||
A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B Proceeding/Conference:Hepatology | 2011 | 90 | ||
2015 | ||||
2011 | 44 |